Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Samsung
 More »

  • Samsung Biologics, BMS in Manufacturing Partnership
    Bristol-Myers Squibb (BMS) and Samsung Biologics have entered into a 10-year agreement under which Samsung will manufacture a commercial antibody cancer drug for BMS at its ...
    7-29-2013
  • Biosimilars: 10 Drugs to Watch
    ... On April 5, Lonza issues statement denying news reports that it will end its biosimilar joint venture with Teva 4 Samsung Biologics: Venture between Samsung and Quintiles halts ...
    4-22-2013
  • Electronics Giants Set Sights on Biotech
    Samsung, Sony eye life-sci's higher growth as consumer electronics sales flatten. After spending decades trying to outdo each other in consumer electronics, Samsung and Sony have ...
    4-1-2013
  • Biosimilars: Not So Far So Fast
    ... this year and in the U.S. in 2018. Samsung bailed on its Rituxan program in October ... Merck announced this February that it had entered into an agreement with Samsung Bioepis ...
    3-15-2013
  • Electronics Giant Samsung Makes First Big Biotech Play
    Merck entered into an agreement with Samsung Bioepis to develop and commercialize multiple prespecified and undisclosed biosimilar candidates. Samsung Bioepis, which is a joint ...
    2-20-2013
  • Biosimilars Now Just About Ready to Roll
    ... Baxter International and Momenta Pharmaceuticals entered into a global collaboration in December 2011 to develop and commercialize up to six follow-on biologic compounds. Samsung ...
    9-1-2012
  • Automation Pioneer Enters Life Sciences
    Brooks Automation supplies robotic systems to Samsung, Intel, and other leading semiconductor companies. Semiconductor manufacturing often takes place in very cold conditions, and ...
    8-1-2012
  • Firms Are Upping the Stakes on mAb Biosimilar Development
    ... On December 6, Biogen Idec and Seoul-based conglomerate Samsung reported that they have ... will be funded with $255 million from Samsung and $45 million from Biogen; Biogen will ...
    12-16-2011
  • IntegenX Scores $40M to Commercialize DNA Identification System
    and joins existing investors Domain Associates, QuestMark Partners, Greenspring Associates, Cross Creek Capital, RONAholdings LLC, Samsung Ventures, and strategic partner In-Q-Tel. ...
    12-13-2011
  • Biogen Idec, Samsung Establish $300M Biosimilar Joint Venture
    Biogen Idec and Samsung established a $300 million joint venture to develop and market biosimilars. The initiative, based in Korea, will be led by Samsung, which will contribute ...
    12-6-2011
  • Samsung Stakes Out Biopharma Position
    Manufacturing Researchers at Samsung Biologics have extensive experience working with many types of mammalian cell lines. Samsung, the South Korean company best known to ...
    11-15-2011
  • Fujifilm and Dr. Reddy's Ink Pact Covering Generic Drugs in Japan
    The expansion is anticipated to be validated and fully operational by the first quarter of 2012. The other hi-tech company making a play in biopharma is Samsung. Almost six months ...
    7-28-2011
  • Biosimilars Proceed with Caution from Starting Gate
    ... Even Samsung, the consumer electronics giant, announced a $389 billion investment in biosimilars in 2010. Yet Roche, in deciding to defend its $6 billion-per-year Avastin franchise ...
    5-15-2011
  • High-Tech Companies Buy Into Biomanufacturing
    Samsung and Fujifilm believe such high-investment diversification will help business. Do ... Samsung established a joint venture (JV) with Quintiles, and Fujifilm bought Merck's ...
    3-18-2011
  • Pfizer to Study Liver Cancer in Korean Patients with Samsung...
    Pfizer formed a research partnership with Samsung Medical Center to generate ... A research team led by Samsung Medical Center scientists including Prof. Park Cheol-Guen, ...
    7-14-2010

  • Journal Articles

  • Continued Suppression of Serum TSH Level May Be Attributed to...
    Yun Jae Chung, Byung Wan Lee, Ji-Youn Kim, Jung Hwa Jung, Yong-Ki Min, Myung-Shik Lee, Moon-Kyu Lee, Kwang-Won Kim, Jae Hoon Chung
    Thyroid
    We reviewed the medical records of patients with Graves' disease between 1995 and 2002 at Samsung Medical Center. We selected 167 Graves' patients who had been euthyroid for at ...
  • Prevalence, Clinical and Ultrasonographic Characteristics of...
    Hahn Wook Kang, Jung Heyun No, Jae Hoon Chung, Yong-Ki Min, Myung-Shik Lee, Moon-Kyu Lee, Jung Hyun Yang, Kwang-Won Kim
    Thyroid
    Retrospective review was done on 1475 patients who had visited Samsung Medical Center, Soul Korea from January 1999 to December 2000. The prevalence of thyroid incidentalomas was ...
  • Lack of a Genetic Association Between the CTLA-4 Gene and Graves...
    Hyun-Jung Cho, Jae Hoon Chung, In Sook Kim, Hee-Jin Kim, Seung Hee Cho, Chang-Seok Ki, Jong-Won Kim
    Thyroid
    Two hundred seventy-eight Korean patients with GD from the Thyroid Clinic and 472 healthy controls from the Health Screening Center of Samsung Medical Center were enrolled in this ...
  • RET Proto-Oncogene Mutations Are Restricted to Codon 634 and...
    Yun Jae Chung, Hyung-Hoon Kim, Hyun-Jin Kim, Yong-Ki Min, Myung-Shik Lee, Moon-Kyu Lee, Kwang-Won Kim, Chang-Seok Ki, Jong-Won Kim, Jae Hoon Chung
    Thyroid
    MTC. Genomic DNAs were obtained from 33 patients with MTC (M:F = 10:23, 39.8 ± 12.0 years) who underwent total thyroidectomy between 1997 and 2003 at the Samsung Medical Center. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll